APA (7th ed.) Citation

Acosta-Torres, S., Murdock, T., Matsuno, R., Beavis, A. L., Stone, R. L., Wethington, S. L., . . . Fader, A. N. (2020). The addition of metformin to progestin therapy in the fertility-sparing treatment of women with atypical hyperplasia/endometrial intraepithelial neoplasia or endometrial cancer: Little impact on response and low live-birth rates. Gynecologic oncology, 157(2), 348-356. https://doi.org/10.1016/j.ygyno.2020.02.008

Chicago Style (17th ed.) Citation

Acosta-Torres, Stefany, et al. "The Addition of Metformin to Progestin Therapy in the Fertility-sparing Treatment of Women with Atypical Hyperplasia/endometrial Intraepithelial Neoplasia or Endometrial Cancer: Little Impact on Response and Low Live-birth Rates." Gynecologic Oncology 157, no. 2 (2020): 348-356. https://doi.org/10.1016/j.ygyno.2020.02.008.

MLA (9th ed.) Citation

Acosta-Torres, Stefany, et al. "The Addition of Metformin to Progestin Therapy in the Fertility-sparing Treatment of Women with Atypical Hyperplasia/endometrial Intraepithelial Neoplasia or Endometrial Cancer: Little Impact on Response and Low Live-birth Rates." Gynecologic Oncology, vol. 157, no. 2, 2020, pp. 348-356, https://doi.org/10.1016/j.ygyno.2020.02.008.